Perimeter Joins Industry Relations Council of the American Society of Breast Surgeons
Perimeter Medical Imaging AI (OTCQX:PYNKF) has joined the Industry Relations Council (IRC) of the American Society of Breast Surgeons (ASBrS), marking a strategic alliance in the breast surgery field. The ASBrS serves as the primary leadership organization for breast surgery specialists, focusing on excellence in patient care.
The company is currently commercializing its S-Series OCT system while awaiting FDA review of their PMA application for the next-generation AI-enabled B-Series OCT product. This membership positions Perimeter alongside established industry players in breast disease diagnosis and treatment.
Perimeter Medical Imaging AI (OTCQX:PYNKF) è entrata a far parte dell'Industry Relations Council (IRC) della American Society of Breast Surgeons (ASBrS), segnando un'alleanza strategica nel settore della chirurgia mammaria. L'ASBrS rappresenta l'organizzazione di riferimento per i chirurghi della mammella, con un focus sull'eccellenza nella cura del paziente.
L'azienda sta commercializzando il suo S-Series OCT system mentre attende la revisione FDA della domanda PMA per il prodotto B-Series OCT di nuova generazione con intelligenza artificiale. Questa adesione colloca Perimeter accanto ad aziende consolidate nella diagnosi e nel trattamento delle patologie mammarie.
Perimeter Medical Imaging AI (OTCQX:PYNKF) se ha unido al Industry Relations Council (IRC) de la American Society of Breast Surgeons (ASBrS), marcando una alianza estratégica en el ámbito de la cirugía mamaria. La ASBrS es la principal organización de referencia para especialistas en cirugía de la mama, centrada en la excelencia en la atención al paciente.
La compañía está comercializando su S-Series OCT system mientras espera la revisión de la FDA de su solicitud PMA para el producto B-Series OCT de próxima generación con IA. Esta membresía sitúa a Perimeter junto a actores consolidados en el diagnóstico y tratamiento de las enfermedades mamarias.
Perimeter Medical Imaging AI (OTCQX:PYNKF)가 American Society of Breast Surgeons(ASBrS)의 Industry Relations Council(IRC)에 가입하여 유방 수술 분야에서 전략적 제휴를 맺었습니다. ASBrS는 환자 치료의 우수성을 중심으로 하는 유방 수술 전문의들의 대표 단체입니다.
회사는 현재 S-Series OCT system을 상용화하고 있으며, 차세대 AI 탑재 B-Series OCT 제품에 대한 PMA 신청의 FDA 심사를 기다리고 있습니다. 이번 가입으로 Perimeter는 유방 질환 진단 및 치료 분야의 기존 주요 업체들과 어깨를 나란히 하게 되었습니다.
Perimeter Medical Imaging AI (OTCQX:PYNKF) a rejoint l'Industry Relations Council (IRC) de l'American Society of Breast Surgeons (ASBrS), marquant une alliance stratégique dans le domaine de la chirurgie mammaire. L'ASBrS est l'organisation de référence pour les chirurgiens du sein, axée sur l'excellence des soins aux patients.
La société commercialise actuellement son S-Series OCT system et attend l'examen par la FDA de sa demande PMA pour le produit B-Series OCT de nouvelle génération, doté d'une IA. Cette adhésion place Perimeter aux côtés d'acteurs établis dans le diagnostic et le traitement des affections mammaires.
Perimeter Medical Imaging AI (OTCQX:PYNKF) ist dem Industry Relations Council (IRC) der American Society of Breast Surgeons (ASBrS) beigetreten und geht damit eine strategische Partnerschaft im Bereich der Brustchirurgie ein. Die ASBrS ist die führende Fachgesellschaft für Brustchirurgen und legt den Schwerpunkt auf exzellente Patientenversorgung.
Das Unternehmen bringt derzeit sein S-Series OCT system auf den Markt und wartet auf die FDA-Prüfung des PMA-Antrags für das KI-gestützte B-Series OCT-Produkt der nächsten Generation. Durch die Mitgliedschaft reiht sich Perimeter neben etablierten Akteuren in der Diagnose und Behandlung von Brustkrankheiten ein.
- None.
- None.
ASBrS is the primary leadership organization for general surgeons who treat patients with breast disease and is committed to continually improving the practice of breast surgery by serving as an advocate for surgeons who seek excellence in the care of breast patients. The ASBrS Industry Relations Council (IRC) is comprised of companies involved in the diagnosis, treatment, and care of breast disease, and who would like to connect in a more significant way with key leaders in breast surgery.
"We welcome Perimeter as a member company of our IRC at a pivotal time for the field," said ASBrS President, Dr. Michael Berry. "While there have been many exciting advancements in breast care over the past few years, there is no question that programs that support optimal and cost-effective care for our patients is a priority for collaboration between industry and our organization."
"We are honored to join other companies – both established and emerging – on the ASBrS IRC as we continue to gain commercial traction with our current S-Series OCT system, while, at the same time, work closely with the
About Perimeter Medical Imaging AI, Inc.
Based in
Perimeter B-Series OCT is limited by
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, information regarding the potential benefits of Perimeter S-Series OCT and Perimeter B-Series OCT, the expected benefits of Perimeter's updated version of its ImgAssist AI, and Perimeter's expectations regarding the PMA submission to the FDA are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Management Discussion and Analysis for the year ended December 31, 2023, which is available on Perimeter's SEDAR+ profile at https://www.sedarplus.ca, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.
CONTACTS:
Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Email: skilmer@perimetermed.com
Susan Thomas
Media Relations
Direct: 619-540-9195
Email: susan@endpointcommunications.net
Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: investors@perimetermed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/perimeter-joins-industry-relations-council-of-the-american-society-of-breast-surgeons-302548262.html
SOURCE Perimeter Medical Imaging AI Inc.
FAQ
What is the significance of Perimeter Medical joining the ASBrS Industry Relations Council?
What products does Perimeter Medical (PYNKF) currently have in development?
Who is the CEO of Perimeter Medical (PYNKF)?
What is the American Society of Breast Surgeons (ASBrS)?
